Woodline Partners »

Arcus Biosciences Incorporated shares owned by Woodline Partners

Quarter-by-quarter ownership of Arcus Biosciences Incorporated (RCUS) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Arcus Biosciences Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Arcus Biosciences Incorporated held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcus Biosciences Incorporated by Woodline Partners

Quarter filed Position value Share count Share price at filing
2023-09-30 $19M 1.0M 17.95
2023-06-30 $5.0M 248k 20.31
2022-12-31 $25M 1.2M 20.68
2022-03-31 $8.2M 261k 31.56
2021-12-31 $69M 1.7M 40.47
2021-09-30 $59M 1.7M 34.87
2021-06-30 $46M 1.7M 27.46
2021-03-31 $35M 1.2M 28.08
2020-03-31 $1.4M 99k 13.88

More positions owned by Woodline Partners

Activision Blizzard
Abbvie (ABBV)
Analog Devices (ADI)
Eli Lilly & Co. (LLY)
Johnson & Johnson (JNJ)
Permian Resources Corp Class A Com (PR)
Regeneron Pharmaceuticals (REGN)
Asml Holding N V N Y Registry Shs (ASML)
Meta Platforms Cl A (META)
Electronic Arts (EA)
EQT Corporation (EQT)
Autodesk (ADSK)
L3harris Technologies (LHX)
Merck & Co (MRK)
Pioneer Natural Resources (PXD)

View all positions for Woodline Partners

Top funds holding Arcus Biosciences Incorporated

Vanguard Group
Octagon Capital Advisors
Invus Financial Advisors
Boxer Capital
Dimensional Fund Advisors
Alliancebernstein
Decheng Capital
Point72 Asset Management
Goldman Sachs Group
Bnp Paribas Investment Partners
Balyasny Asset Management
Charles Schwab Investment Management
Bank of New York Mellon
Ikarian Capital
Ubs Global Asset Management Americas

View all funds holding Arcus Biosciences Incorporated